{"organizations": [], "uuid": "42b74ad0f6031b18a194d7626789f7cf281cac1c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-hc2-announces-pansend-life-science/brief-hc2-announces-pansend-life-sciences-portfolio-companybenevir-biopharm-to-be-acquired-by-janssen-biotech-for-up-to-1-04-bln-idUSFWN1S90NG", "country": "US", "domain_rank": 408, "title": "BRIEF-HC2 Announces Pansend Life Sciences Portfolio Company Benevir Biopharm To Be Acquired By Janssen Biotech For Up To $1.04 Bln", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-02T14:10:00.000+03:00", "replies_count": 0, "uuid": "42b74ad0f6031b18a194d7626789f7cf281cac1c"}, "author": "", "url": "https://www.reuters.com/article/brief-hc2-announces-pansend-life-science/brief-hc2-announces-pansend-life-sciences-portfolio-companybenevir-biopharm-to-be-acquired-by-janssen-biotech-for-up-to-1-04-bln-idUSFWN1S90NG", "ord_in_thread": 0, "title": "BRIEF-HC2 Announces Pansend Life Sciences Portfolio Company Benevir Biopharm To Be Acquired By Janssen Biotech For Up To $1.04 Bln", "locations": [], "entities": {"persons": [{"name": "janssen", "sentiment": "none"}], "locations": [], "organizations": [{"name": "pansend life sciences portfolio company", "sentiment": "negative"}, {"name": "janssen biotech", "sentiment": "negative"}, {"name": "biopharm", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "holdings inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Market News May 2, 2018 / 11:10 AM / Updated 12 minutes ago BRIEF-HC2 Announces Pansend Life Sciences Portfolio Company Benevir Biopharm To Be Acquired By Janssen Biotech For Up To $1.04 Bln Reuters Staff 1 Min Read\nMay 2 (Reuters) - HC2 Holdings Inc:\n* HC2 ANNOUNCES PANSEND LIFE SCIENCES PORTFOLIO COMPANY BENEVIR BIOPHARM TO BE ACQUIRED BY JANSSEN BIOTECH, INC. FOR UP TO $1.04 BILLION\n* HC2 HOLDINGS INC - JANSSEN WILL MAKE AN UPFRONT CASH PAYMENT OF $140 MILLION AT CLOSING OF TRANSACTION\n* HC2 HOLDINGS - JANSSEN TO ALSO MAKE ADDITIONAL CONTINGENT PAYMENTS OF UP TO $900 MILLION BASED ON ACHIEVEMENT OF CERTAIN PREDETERMINED MILESTONES\n* HC2 HOLDINGS INC - TOTAL AMOUNT OF ALL PAYMENTS AS PART OF DEAL COULD EXCEED $1 BILLION IF ALL MILESTONES ARE MET Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-05-02T14:10:00.000+03:00", "crawled": "2018-05-02T14:26:45.001+03:00", "highlightTitle": ""}